Increased neuroendocrine tumours, but small colorectal cancer incidence in patients with inflammatory bowel disease treated by mesalazine

BAŞARANOĞLU, METİNKapsigay, MustafaKUNDUZ, ENVER2020-06-052020-06-052020-06-01BAŞARANOĞLU M., Kapsigay M., KUNDUZ E., -Increased neuroendocrine tumours, but small colorectal cancer incidence in patients with inflammatory bowel disease treated by mesalazine-, EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, cilt.32, ss.763, 2020https://hdl.handle.net/20.500.12645/18071Increased neuroendocrine tumours, but small colorectal cancer incidence in patients with inflammatory bowel disease treated by mesalazineArticleWOS:0005321971000158508430992310.1097/meg.000000000000169332355096